HiberGene’s PCR Adapt COVID-19/Flu Combo is an RT-qPCR test for the direct detection and differentiation of SARS-CoV-2, Influenza A and Influenza B nucleic acid sequences in human nasopharyngeal samples, without sample extraction.
Benefits:
- Detects two separate SARS-CoV-2 genes (N & Orf1ab)
-
FAST detection (70-80 Mins)
-
ACCURATE diagnosis:
98-100% sensitivity, 100% specificity -
EASY – Low-complexity direct testing protocol
-
Multi-platform compatibility
-
High throughput capacity
Clinical Sensitivity & Specificity – BioRad CFX96:
Product Features:
Protocol: